← Open Payments lookup

DAVID GUO: Open Payments

NPI 1629664131 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 21 payments from 9 companies in 2025. Trend: 2023 $143 · 2024 $1,265 · 2025 $870

Food & beverage: $736Education: $134
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$232
Alkermes, Inc.2$145
ABBVIE INC.5$125
Vanda Pharmaceuticals Inc.1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$68
Janssen Pharmaceuticals, Inc2$60
Otsuka Pharmaceutical Development & Commercialization, Inc.1$51
E.R. Squibb & Sons, L.L.C.1$32
Lundbeck LLC1$31

Products named: VRAYLAR, FANAPT, ARISTADA, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY.

Industry payments across HI — which companies pay providers there.